
Bodal Chemicals Limited
The current stock price of Bodal Chemicals Limited is ₹61.45, with a target price range between ₹58.38 and ₹64.52. The stock has experienced a price change of ₹-1.48 (-2.35%), reflecting recent market volatility.
Today's opening price was ₹62.86, while the previous close stood at ₹62.93.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Bodal Chemicals Limited Price Chart
Bodal Chemicals Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 62.86
- Previous Close Price: 62.93
- Change: -0.07%
- Total Traded Volume: 2,270
- Total Buy Quantity: 23,449
- Total Sell Quantity: 38,124
Price | Buy Qty | Sell Qty |
---|---|---|
62.23 | 25.00 | 0.00 |
62.25 | 1.00 | 0.00 |
62.50 | 1.00 | 0.00 |
62.70 | 121.00 | 0.00 |
62.85 | 100.00 | 0.00 |
62.86 | 0.00 | 356.00 |
62.93 | 0.00 | 25.00 |
63.00 | 0.00 | 1.00 |
63.75 | 0.00 | 3,874.00 |
63.78 | 0.00 | 1,030.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
Bid | Qty | Ask | Qty |
---|---|---|---|
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
Shareholding Patterns of Bodal Chemicals Limited
Key Trade Statistics of Bodal Chemicals Limited
Trade Information | Details |
---|---|
Traded Volume (Lakhs) | 3.84 |
Traded Value (₹ Cr.) | 2.39 |
Total Market Cap (₹ Cr.) | 773.93 |
Free Float Market Cap (₹ Cr.) | 325.42 |
Impact cost | 0.17 |
Quantity Traded | 384,167.00 |
Deliverable Quantity | 202,292.00 |
% of Quantity to Traded | 52.66 |
Security VaR | 16.93 |
Index VaR | N/A |
VaR Margin | 16.93 |
Extreme Loss Rate | 3.5 |
Adhoc Margin | N/A |
Applicable Margin Rate | 20.43 |
Face Value | 2 |
Key Price Statistics of Bodal Chemicals Limited
The 52-week high for Bodal Chemicals Limited was ₹89.20, recorded on 12-Mar-2024. On the other hand, the 52-week low stands at ₹50.01, with the lowest value recorded on 03-Mar-2025.
The upper band for trading is ₹75.51, and the lower band is ₹50.34. The price band is 20%.
The stock's daily volatility stands at 2.61, while the annualized volatility is 49.86. The tick size for trading is ₹0.01.
Price Information | Details |
---|---|
52 Week High (12-Mar-2024) | 89.20 |
52 Week Low (03-Mar-2025) | 50.01 |
Upper Band | 75.51 |
Lower Band | 50.34 |
Price Band (%) | 20 |
Daily Volatility | 2.61 |
Annualised Volatility | 49.86 |
Tick Size | 0.01 |
Key Securities Statistics of Bodal Chemicals Limited
Securities Information | Details |
---|---|
Status | Listed |
Trading Status | Active |
Date of Listing | 22-Aug-2011 |
Adjusted P/E | 108.77 |
Symbol P/E | 131.24 |
Index | NA |
Macro-Economic Sector | Commodities |
Sector | Chemicals |
Industry | Chemicals & Petrochemicals |
Basic Industry | Dyes And Pigments |
Security Status of Bodal Chemicals Limited
Title | Details |
---|---|
Board Status | Main |
Trading Segment | Normal Market |
Session No. | - |
Class of Shares | Equity |
SDD Compliance | - |
Name of Compliance Officer | - |
Announcements of Bodal Chemicals Limited
Subject | Date |
---|---|
Updates | 08-Mar-2025 |
Integrated Filing- Financial | 17-Feb-2025 |
Analysts/Institutional Investor Meet/Con. Call Updates | 17-Feb-2025 |
Analysts/Institutional Investor Meet/Con. Call Updates | 13-Feb-2025 |
Copy of Newspaper Publication | 12-Feb-2025 |
Investor Presentation | 10-Feb-2025 |
Investor Presentation | 10-Feb-2025 |
Outcome of Board Meeting | 10-Feb-2025 |
Corporate Actions of Bodal Chemicals Limited
Face Value | Purpose | Ex-Date |
---|---|---|
2 | Annual General Meeting | 20-Sep-2024 |
2 | Annual General Meeting/Dividend - Rs 0.10 Per Share | 22-Sep-2023 |
2 | Annual General Meeting/Dividend - Rs 0.80 Per Share | 22-Sep-2022 |
2 | Annual General Meeting/Dividend - Rs 0.80 Per Share | 16-Sep-2021 |
2 | Annual General Meeting | 13-Aug-2020 |
2 | Interim Dividend - Re 0.80 Per Share | 18-Feb-2020 |
2 | Annual General Meeting/Dividend - Rs 0.80 Per Share | 12-Sep-2019 |
2 | Annual General Meeting/Dividend Re 0.80 Per Share | 06-Sep-2018 |
2 | Annual General Meeting/Dividend - Re 0.50 Per Share | 14-Sep-2017 |
2 | Annual General Meeting | 15-Sep-2016 |
2 | Interim Dividend - Re 0.30/- Per Share (Purpose Revised) | 11-Aug-2016 |
2 | Interim Dividend - Re 0.40/- Per Share (Purpose Revised) | 17-Mar-2016 |
2 | Annual General Meeting/ Interim Dividend - Re 0.20/- Per Share | 20-Aug-2015 |
2 | Annual General Meeting | 11-Sep-2014 |
2 | Annual General Meeting | 20-Sep-2013 |
2 | Annual General Meeting | 20-Sep-2012 |
2 | Dividend-Re.0.54 Per Share | 22-Sep-2011 |
Board Meetings of Bodal Chemicals Limited
Financial Results of Bodal Chemicals Limited
Company Directory of Bodal Chemicals Limited
Web Address | Office | Address | City |
---|---|---|---|
www.bodal.com | Registered Office | Bodal Corporate House, Besides Maple Green Residency, Nr. Shilaj Ring Road Circle, Thaltej | AHMEDABAD |
www.bodal.com | Transfer Agent | Link Intime India Pvt. Ltd C-101, 247 Park LBS Marg Vikhroli West | MUMBAI |
Insider Trading of Bodal Chemicals Limited
Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
---|---|---|---|
7(2) | Shakuntala J Patel | 0 | Buy |
7(2) | Ramesh D Patel | 783190 | Buy |
7(2) | Ramesh D Patel | 607017 | Buy |
7(2) | Ramesh D Patel | 1400706 | Buy |
7(2) | Bhavin S. Patel | 4595061 | Buy |
7(2) | Bhavin S. Patel | 24589057 | Buy |
7(2) | Bhavin S. Patel | 36026155 | Buy |
7(2) | Bhavin S. Patel | 59809273 | Buy |
7(2) | Shakuntala J Patel | 0 | Buy |
7(2) | Ramesh D Patel | 1474949 | Buy |
7(2) | Ramesh D Patel | 3411049 | Buy |
7(2) | Ramesh D Patel | 114730 | Buy |
7(2) | Ramesh D Patel | 4735507 | Buy |
7(2) | Suresh J. Patel | 38765855 | Buy |
7(2) | Suresh J. Patel | 11521933 | Buy |
7(2) | Ankit S. Patel | 18171998 | Buy |
7(2) | Ankit S. Patel | 12082033 | Buy |
7(2) | SURESHBHAI JAYANTIBHAI PATEL | 23968488 | Buy |
7(2) | SURESHBHAI JAYANTIBHAI PATEL | 71502772 | Buy |
7(2) | Ankit S. Patel | 23366152 | Buy |
Annual Reports of Bodal Chemicals Limited
Investor Complaints of Bodal Chemicals Limited
Event Calendar of Bodal Chemicals Limited
Purpose | Details |
---|---|
Results/Others | For consideration and approval of Un-Audited financial results for the quarter ended on September 30, 2011 and any other business with the permission of the Chairman. |
Results/Others | For consideration and approval of Un-Audited financial results for the quarter ended on December 31, 2011 and any other business with the permission of the Chairman. |
Results/Others | For consideration and approval of Un-Audited financial results for the quarter ended on December 31, 2011 and any other business with the permission of the Chairman. |
Results/Others | For the following business: 1. To consider and approve Un-Audited Financial Result for the quarter and financial year ended on March 31, 2012. 2. To consider re-appointment of Chairman & Managing Director and Executive Directors of the Company and any other business with the permission of the Chairman. |
Results/Others | For consideration and approval of Un-Audited financial results for quarter ended on June 30, 2012 and any other business with the permission of the Chairman. |
Results/Others | For consideration and approval of Audited Financial Results for the financial year ended on March 31, 2012 and any other business with the permission of the Chairman. |
Results/Others | For Consideration and approval of Un-Audited financial results for quarter and half year ended on September 30, 2012 and any other business with the permission of the Chairman. |
Results/Others | To conduct the following business: 1. To consider, approve and declare of Un-audited financial result for the quarter ended on December 31, 2012; 2. To consider of issue of Preference shares; 3. And any other business with the permission of the Chairman. |
Others | Inter alia, to allot 9% Non Cumulative Redeemable Preference Shares to Promoters / Promoter Group and/or Non Promoters and any other business with the permission of the Chairman. |
Results/Others | To consider and approve Audited Financial Result/Accounts for the financial year and quarter ended on March 31, 2013 and any other business with the permission of the Chairman. |
Results | to consider and approve Un-audited Financial Result for the quarter ended on June 30, 2013 and any other business with the permission of the Chairman. |
Results/Others | To consider and approve Un-audited Financial Result for the quarter and half year ended on September 30, 2013 and any other business with the permission of the Chairman. |
Results/Others | To consider and approve Standalone Un-audited Financial Result for the quarter ended on December 31, 2013 and any others business with the permission of the Chairman. |
Results | To transact the following business: To consider and approve Audited Financial Results/Accounts for the financial year and quarter ended on 31st March, 2014 and any other business with the permission of the Chairman. Further, Under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 1992 and Company Code of Conduct for Prevention of Insider Trading & Code for Corporate Disclosure Practices, Company has informed all the concerned persons that trading window for dealing in securities of the Company will be closed from 20th May, 2014 to 29th May, 2014 (both days inclusive) and the trading window will re-open w.e.f. 30th May, 2014. |
Results/Others | To consider and approve Standalone Un-audited Financial Result for the quarter ended on June 30, 2014 and any other business with the permission of the Chairman. Further, Under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 1992 and the Company's Code of Conduct for Prevention of Insider Trading & Code for Corporate Disclosure Practices, Company has informed all the "concerned persons" that trading window for dealing in securities of the Company will be closed from July 22, 2014 to July 31, 2014 (both days inclusive) and the trading window will re-open w.e.f. August 1, 2014. |
Results | To consider and approve Standalone Un-audited Financial Result for the quarter and half year ended on September 30, 2014 and any other business with the permission of the Chairman. |
Results/Others | To transact the following business : 1. To consider and approve Standalone Un-audited Financial Result for the quarter ended on December 31, 2014. 2. To appoint Women Director and any other business with the permission of the Chairman. |
Results/Others | To transact the following business: 1. To consider and approve Audited Financial Results/Accounts for the quarter and financial year ended on March 31, 2015. 2. To consider re-appointment of Chairman & Managing Director and Executive Directors of the company and any other business with the permission of the Chairman. |
Others | to transact the following business : 1. Consider and redemption of 2,50,00,000, 9% Non Cumulative Redeemable Preference Shares (Non Convertible) of Rs. 10/- each, subject to approval of Preference Share holders; and 2. To fix and finalize the General meeting of the Preference Shareholders of the Company. 3. Any other businesses with the permission of chair. |
Results/Dividend | To transact the following business :1) To consider and approve Standalone Un-audited Financial Result for the quarter ended on 30th June, 2015.2) To consider and declare of Interim Dividend on Equity shares, ifany, for the financial year 2015-16 and;3) Any other business with the permission of the Chairman. |
Results/Others | To consider and approve Standalone Un-audited Financial Result for the quarter and half year ended on September 30, 2015 and any other business with the permission of the Chairman. |
Results/Others | To transact the following business : To consider and approve Standalone Un-audited Financial Result for the quarter and nine months ended on December 31, 2015 and any other business with the permission of the Chairman.. |
Dividend | To transact the following business : 1. To consider amalgamation of Bodal Agrotech Ltd. (wholly owned subsidiary company) having Registered office at Plot No. 123-124, Phase-I, G.I.D.C., Vatva, Ahmedabad with the company subject to approval of Hon'ble High Court of Gujarat and other regulatory authorities and to carry out all other work relating to amalgamation including approval of draft scheme of amalgamation; 2. To consider and declare of 2nd Interim Dividend on Equity shares, if any, for the financial year 2015-16 and such other business with the permission of the Chairman.; |
Results/Others | to transact the following business:1) To consider and approve Standalone and consolidated Audited Financial Results/Accounts for financial year ended on March 31, 2016 along with auditors report there on.2) To consider re-appointment of Mr. Ankit S. Patel as an Executive Directors of the company and any other business with the permission of the Chairman. |
Others | To transact the following business : 1) To consider and discuss expansions of Plants and future growth of the Company, considering available Environmental Clearance and otherwise; 2) And any other business with the permission of the Chairman. |
Results/Dividend | to transact the following business: 1) To consider and approve Standalone Un-audited Financial Result for the quarter ended on June 30, 2016. 2) To consider and declare of 1st Interim Dividend on Equity shares, if any, for the financial year 2016-17 and any other business with the permission of the Chairman. |
Results/Others | To transact the following business:1. To consider and approve Standalone Un-audited Financial Result for the quarter and half year ended September 30, 2016 and any other business with the permission of the Chairman.Further, Under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015, Code Of Conduct For Prohibition Of Insider Trading And Unpublished Price Sensitive Information of Bodal Chemicals Limited, Company has informed all the concerned persons/employees/insiders that trading window for dealing in securities of the Company will be closed from November 3, 2016 to November 12, 2016 (both days inclusive) and the trading window will re-open w.e.f. November 13, 2016. |
Results | To transact the following businesses: a. To consider and approve Standalone Un-audited Financial Result for the quarter and nine months ended December 31, 2016. Further, Under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015, Code Of Conduct For Prohibition Of Insider Trading and Unpublished Price Sensitive Information of Bodal Chemicals Limited, Company has informed all the concerned persons/employees/insider that trading window for dealing in securities of the Company will be closed from February 05, 2017 to February 15, 2017 (both days inclusive) and the trading window will re-open w.e.f. February 16, 2017. |
Acquisition | To transact the following business : To consider and approve to make Investment in a Private Limited company and acquired stake about 70% and make Subsidiary Company of company. |
Others | -- To consider appointment of Additional Director (Woman Director as Independent of the company) - To consider various type of Employee Stock Options Scheme (ESOP) and constitute/ nominate any committee of the Board for ESOP and any other business with the permission of the chairman. |
Results/Others | To Consider and approve Standalone and consolidated Audited Financial Results/Accounts for the Financial Year ended March 31, 2017 along with auditors report there on and any other business with the permission of the Chairman. |
Results/Others | to transact the following business: 1) To consider and approve Standalone Un-audited Financial Result for the quarter ended on June 30, 2017. 2) To consider to issue Equity Shares through Qualified Institutional Placement (QIP) mode, for an amount not exceeding Rs.300 crores. 3) To Considered Scheme of Employee Stock Option Scheme (ESOP) and issue Equity Shares through ESOP to the Employees of the Company. 4) To decide date and venue of Annual General Meeting and dates of Book Closure for AGM and payment of Final Dividend for the year ended 31-03-2017. |
Results/Others | to transact the following businesses: 1) To consider and approve Standalone Un-audited Financial Result for the quarter and half year ended September 30, 2017. 2) To consider appointment of Additional Director as Independent Director of the company. |
Results/Others | , to transact the following businesses: 1) To consider and approve Standalone Un-audited Financial Result for the quarter and nine months ended December 31, 2017 and any other business with the permission of the Chairman. |
Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2018, dividend and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2018 and other business matters |
Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2018 and other business matters |
Financial Results/Dividend/Fund Raising/Other business matters | To consider and approve the financial results for the period ended March 31, 2019, dividend, Fund Raising and other business matters |
Other business matters | To consider other business matters 1. To consider and allot 1,50,00,000 (One Crore fifty lakhs) Equity warrants at a price of Rs. 115/- per warrant including Premium of Rs. 113/- per warrant to the Promoter(s)/Promoter Group and to Non-Promoters of the Company on the preferential basis. 2. To form a ᅡモWarrant Committeeᅡヤ of the Company. 3. To accept and take note of resignation of Dr. Parin D. Shah from the post of Director designated as Independent Director of the Company. Further note that, Company has received resignation from Dr. Parin D. Shah, Independent Director of the Company on today i.e. 05-07-2019. 4. Any other item with the permission of the Chair and Majority of Directors. |
Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2019 and other business matters |
Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended December 31, 2019, dividend and other business matters |
Other business matters | To consider other business matters1. To consider amalgamation of Trion Chemicals Pvt. Ltd. (wholly owned subsidiary company) having Registered office at Plot No. 123-124, Phase-I, G.I.D.C., Vatva, Ahmedabad with our company subject to approval of NCLT(or NCLAT) of Gujarat and other regulatory authorities and to carry out all other work relating to amalgamation including approval of draft scheme of amalgamation;2. To consider and approve reappointment of Mr. Suresh J. Patel as Chairman and Managing Director and fix his remuneration.3. To consider and approve appointment of additional director to be designated as Director HSE on the Board of the Company.4. Any other business with permission of the Chairman. |
Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2020 and other business matters |
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2020 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2020 and other business matters To consider and approve Standalone and Consolidated Unaudited financial result for the quarter and nine months ended 31st December 2020. To consider and approve change of Registered Office of the Company. To incorporate wholly owned subsidiary of the Company in Indonesia. To consider and approve acquisition of Chemical Unit/Plant. and any other business with the permission of the Chairman. |
Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2021, dividend and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2021 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2021 and other business matters |
Other business matters | Bodal Chemicals Limited has informed the Exchange about Board Meeting to be held on 12-Dec-2022 to consider Other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2022 and other business matters |
Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2023, dividend and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
Fund Raising | To consider Fund Raising |
Financial Results | To consider and approve the financial results for the period ended March 31, 2024 |
Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2024 and other business matters |
Share Transfers of Bodal Chemicals Limited
Voting Results of Bodal Chemicals Limited
Date of Mtg. | Mtg. Type | Resolution |
---|---|---|
24-SEP-2024 | AGM | To receive, consider and adopt the Audited Standalone Financial Statement of the company for the financial year ended 31st March 2024 and the reports of the Board of Directors¬タル and Auditors¬タル thereon; and the Audited Consolidated Financial Statement of the company for the financial year ended 31st March 2024 and the reports of Auditors¬タル thereon. |
24-SEP-2024 | AGM | To re-appoint Mr. Rajarshi Ghosh as a Director ¬タモ HSE of the Company: |
24-SEP-2024 | AGM | To ratify remuneration of Cost auditors. |
24-SEP-2024 | AGM | To appoint a Director in place of Mr. Bhavin S. Patel (Holding Din: 00030464), who retires by rotation and being eligible offers himself for reappointment. |
20-AUG-2024 | Postal Ballot | To re-appoint Mr. Ankit S. Patel as an Executive Director of the Company |
03-APR-2024 | EGM | ISSUE OF 1,00,00,000 SHARE WARRANTS, CONVERTIBLE INTO EQUITY SHARES ON PREFERENTIAL BASIS TO THE PERSONS BELONGING TO THE NON PROMOTER CATEGORY |
28-SEP-2023 | AGM | To receive, consider and adopt the AuditednStandalone Financial Statement of the Companynfor the financial year ended 31st March 2023nand the reports of the Board of Directors¬タル andnAuditors¬タル thereon; andnb. the Audited Consolidated Financial Statementnof the Company for the financial year endedn31st March 2023 and the reports of Auditors¬タルnthereon. |
28-SEP-2023 | AGM | To ratify remuneration of Cost auditors. |
28-SEP-2023 | AGM | To appoint a Director in place of Mr. Ankit S. Pateln(Holding Din: 02173231), who retires by rotation andnbeing eligible offers himself for reappointment. |
28-SEP-2023 | AGM | To declare dividend ` 0.10 per equity share (5% on FVnof ` 2/-) on equity shares for the financial year 2022-n23. |
24-JAN-2023 | Postal Ballot | To Appoint Mr. Rohit Maloo as an Independent Director of the Company for period of five years : |
24-JAN-2023 | Postal Ballot | To re-appoint Mr. Bhavin S. Patel as an Executive Director of the Company |
24-JAN-2023 | Postal Ballot | To re-appoint Mr. Suresh J. Patel as a Chairman and Managing Director of the Company |
24-JAN-2023 | Postal Ballot | Alteration of the Objects Clause of the Memorandum of Association of the Company |
26-SEP-2022 | AGM | a. To receive, consider and adopt the Audited Standalone Financial Statement of the company for the financial year ended 31st March 2022 and the reports of the Board of Directors¬タル and Auditors¬タル thereon; and b. the Audited Consolidated Financial Statement of the company for the financial year ended 31st March 2022 and the reports of Auditors¬タル thereon. |
26-SEP-2022 | AGM | To ratify remuneration of Cost auditors |
26-SEP-2022 | AGM | Appointment of M/s. Naresh J. Patel & Co., Chartered Accountants (Firm Registration No.: 123227W) as a Statutory Auditors of the company for the first term of 5 years |
26-SEP-2022 | AGM | To appoint a Director in place of Mr. Rajarshi Gosh (Holding Din: 08715159), who retires by rotation and being eligible offers himself for reappointment. |
26-SEP-2022 | AGM | To declare dividend Rs.0.80 per equity share (40% on FV of Rs. 2/-) on equity shares for the financial year 2021-22 |
21-JUL-2022 | Court Convened Meeting | Approval of the Scheme of Arrangement involving amalgamation of S P S PROCESSORS PRIVATE LIMITED with BODAL CHEMICALS LIMITED under Section 230 to 232 read with other applicable provisions of the Companies Act, 2013 |
FAQs on Bodal Chemicals Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.